The art of saying no in clinical trials goes beyond simply delivering news; it involves maintaining relationships and ...
The conundrum of missing data vs. inter-rater variability.
Tips and best practices for empowering professionals to become change agents in their institutions, including clinical trials ...
In an interview with Applied Clinical Trials Associate Editor Don Tracy, Peter Ronco, CEO, Emmes, provides advice to small biopharma companies looking to scale their clinical programs without ...
In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, CEO, CluePoints, discusses goals of the SCOPE Summit and CluePoints' evolving approach to risk detection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback